Pharmaceutical R&D is focusing on developing more specialized drugs, resulting in increasingly more potent APIs. Therefore, the demand for highly potency drug product manufacturing has been steadily increasing over the years and this trend is expected to continue. With this need comes the importance of various handling procedures, safety controls, and OEL protection. Executing an efficient and optimal highly potent strategy early on can set a strong foundation when it comes time to scale up the manufacture of the highly potent drug product.
Listen to this webinar to hear industry experts, Juliana Woo, Milan Babu and Jonathan Laba, discuss: